ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

NCI Program: DOD’s TRICARE To Cover Patient Costs In NCI Prevention, Early detection Trials

September 10, 1999

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014